Hindustan Research Health Products Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 10-01-2025
- Paid Up Capital ₹ 4.30 M
as on 10-01-2025
- Company Age 34 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 1.50 M
as on 10-01-2025
- Revenue 24.63%
(FY 2023)
- Profit 87.50%
(FY 2023)
- Ebitda 16.88%
(FY 2023)
- Net Worth -0.32%
(FY 2023)
- Total Assets 0.44%
(FY 2023)
About Hindustan Research Health Products
The Corporate was formerly known as Hindustan Research Health Products Limited. The Company is engaged in the Real Estate And Construction Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 4.30 M.
The company has closed loans amounting to ₹1.50 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Pramodkumar Pasi, Kavita Bukalsariya, and Pawan Bukalsaria serve as directors at the Company.
- CIN/LLPIN
U65990MH1990PTC056175
- Company No.
056175
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Apr 1990
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Hindustan Research Health Products?
Board Members(3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Pramodkumar Pasi | Director | Current | |
Kavita Bukalsariya | Director | 01-Sep-2005 | Current |
Pawan Bukalsaria | Director | 01-Dec-1999 | Current |
Financial Performance of Hindustan Research Health Products.
Hindustan Research Health Products Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 24.63% increase. The company also saw a substantial improvement in profitability, with a 87.5% increase in profit. The company's net worth dipped by a decrease of 0.32%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Hindustan Research Health Products?
Unlock access to Hindustan Research Health Products's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Bombay Mercantile Co.Op. Bank Limited Creation Date: 25 Mar 1994 | ₹1.50 M | Satisfied |
How Many Employees Work at Hindustan Research Health Products?
Unlock and access historical data on people associated with Hindustan Research Health Products, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hindustan Research Health Products, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hindustan Research Health Products's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.